AngioDynamics Inc (ANGO) company profile

AngioDynamics designs, manufactures, and markets medical devices and technologies used to treat cardiovascular disease and cancer. The company operates through two main business segments: Med Tech and Med Device. Its product portfolio includes atherectomy systems, mechanical thrombectomy and venous drainage devices, thrombolytic catheters, irreversible electroporation and microwave tissue ablation platforms, angiographic catheters, guidewires, drainage catheters, micropuncture kits, and implantable ports. Its target customers and end users include interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses.

The company markets its products in the United States primarily through a direct sales team and internationally via direct sales and distributor arrangements across regions such as the European Union. AngioDynamics conducts manufacturing operations across two leased properties in Queensbury and Glens Falls, New York, while also utilizing third-party production facilities and leased distribution warehouses. The company maintains its corporate headquarters in Latham, New York.

Summary of the business section of AngioDynamics's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“As of May 31, 2026, we had approximately 632 full time employees.”